Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of Akero Therapeutics Inc (NASDAQ: AKRO) closed at $49.65 in the last session, up 3.37% from day before closing price of $48.03. In other words, the price has increased by $3.37 from its previous closing price. On the day, 2.94 million shares were traded.
Ratios:
We take a closer look at AKRO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 16.80 and its Current Ratio is at 16.80. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on January 30, 2025, Upgraded its rating to Buy and sets its target price to $63 from $35 previously.
On January 27, 2025, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $50 to $72.
On November 18, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $65.Citigroup initiated its Buy rating on November 18, 2024, with a $65 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 22 ’25 when Lamy Patrick sold 4,000 shares for $50.00 per share. The transaction valued at 200,000 led to the insider holds 33,492 shares of the business.
PATRICK D LAMY bought 10,000 shares of AKRO for $483,500 on May 22 ’25. On May 15 ’25, another insider, Yale Catriona, who serves as the Chief Development Officer of the company, sold 10,000 shares for $39.30 each. As a result, the insider received 392,978 and left with 95,034 shares of the company.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $58.40, while it has fallen to a 52-week low of $17.86. The 50-Day Moving Average of the stock is 19.15%, while the 200-Day Moving Average is calculated to be 39.42%.
Shares Statistics:
A total of 79.67M shares are outstanding, with a floating share count of 71.70M. Insiders hold about 10.06% of the company’s shares, while institutions hold 101.99% stake in the company.
